In renal cell carcinoma, TRIM21 mediates ubiquitination-mediated degradation of sterol regulatory element binding transcription factor 1 (SREBF1) to inhibit the expression of lipogenic enzymes, thereby blocking lipogenesis and tumor development (Chen et al., 2023). This evidence concerns the gene SREBF1 and hereditary clear cell renal cell carcinoma.